Drug intelligence / Profile preview

咽炎清滴丸

Development stage: Unknown
Lead developer: Yantai Dongcheng Pharmaceutical
Modality: Small Molecules
Administration: Buccal, Sublingual

Overview

咽炎清滴丸 (Yanyanqing Dripping Pills) is a traditional Chinese patent medicine developed and marketed by Yantai Dongcheng Pharmaceutical (specifically manufactured by its subsidiary Yantai Dongcheng Dayang Pharmaceutical). It is formulated as a dripping pill containing active botanical and natural ingredients, including Sarcandra glabra (肿节风), L-borneol (艾片), and menthol (薄荷脑). The medicine is indicated for clearing heat, detoxifying, relieving swelling, and alleviating pain. It is clinically used to treat throat and oral diseases such as acute and chronic pharyngitis (喉痹), recurrent aphthous stomatitis and herpetic stomatitis (口疮), and periodontitis (牙周炎).

Other names: Yanyanqing DiwanYanyanqing Dripping Pills咽炎清滴丸 48粒

Targets

IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on 咽炎清滴丸.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 咽炎清滴丸.